Variant report
Variant | esv3380722 |
---|---|
Chromosome Location | chr2:209241407-209244005 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs564814862 | chr2:209241428-209241429 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs56834217 | chr2:209241461-209241462 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
3 | rs377114481 | chr2:209241471-209241472 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs576946452 | chr2:209241483-209241484 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs148612620 | chr2:209241496-209241497 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs142059980 | chr2:209241507-209241508 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs532245323 | chr2:209241592-209241593 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs533081308 | chr2:209241606-209241607 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs550176295 | chr2:209241649-209241650 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs150756307 | chr2:209241742-209241743 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs184513022 | chr2:209241743-209241744 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs541987169 | chr2:209241751-209241752 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs561666568 | chr2:209241762-209241763 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs568719290 | chr2:209241782-209241783 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs527314556 | chr2:209241790-209241791 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs548097059 | chr2:209241828-209241829 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs571141729 | chr2:209241841-209241842 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs533334506 | chr2:209241850-209241851 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs13021081 | chr2:209241861-209241862 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
20 | rs570011540 | chr2:209241898-209241899 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs10181047 | chr2:209241939-209241940 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
22 | rs9712104 | chr2:209241968-209241969 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs555487364 | chr2:209241995-209241996 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs565715239 | chr2:209242015-209242016 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs534730023 | chr2:209242031-209242032 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs189226257 | chr2:209242038-209242039 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs377408400 | chr2:209242047-209242048 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs4589687 | chr2:209242070-209242071 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs545641015 | chr2:209242091-209242092 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs556315022 | chr2:209242125-209242126 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs200040469 | chr2:209242126-209242127 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs149551319 | chr2:209242133-209242134 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs7582175 | chr2:209242170-209242171 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs534888719 | chr2:209242171-209242172 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs4268880 | chr2:209242184-209242185 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs537494898 | chr2:209242185-209242186 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs370772372 | chr2:209242186-209242187 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs527247969 | chr2:209242191-209242192 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs4268881 | chr2:209242202-209242203 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs533686581 | chr2:209242211-209242212 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs550245474 | chr2:209242225-209242226 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs7582376 | chr2:209242227-209242228 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
43 | rs529471713 | chr2:209242247-209242248 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs549050394 | chr2:209242252-209242253 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs565851336 | chr2:209242253-209242254 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs71418683 | chr2:209242264-209242265 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
47 | rs13400597 | chr2:209242284-209242285 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs551762244 | chr2:209242286-209242287 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs571593894 | chr2:209242289-209242290 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs7582480 | chr2:209242337-209242338 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
Disease | PMID | Source |
---|---|---|
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Ependymoma | 16718352 | CNVD |
Melanoma | 18172304 | CNVD |
Cancer | 16751803 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Breast cancer | 17603634 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Breast cancer | 16272173 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Cancer | 21637783 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Liposarcoma | 21253554 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Embryonal rhabdomyosarcoma | 16790082 | CNVD |
Autism | 16446308 | CNVD |
Autism | 19401682 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Lung cancer | 18438408 | CNVD |
Prostate cancer | 18632612 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Biliary cancer | 20360734 | CNVD |
Breast cancer | 20360734 | CNVD |
Coronary artery disease | 20360734 | CNVD |
Crohn''s disease | 20360734 | CNVD |
Hypertension | 20360734 | CNVD |
Rheumatoid arthritis | 20360734 | CNVD |
Type 1 diabetes | 20360734 | CNVD |
Type 2 diabetes | 20360734 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Cervical cancer | 21062161 | CNVD |
Adenoid cystic carcinoma | 18698036 | CNVD |
Non-muscle invasive bladder neoplasm | 19445696 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Autism | 20808228 | CNVD |
Renal cell carcinoma | 18765545 | CNVD |
Ovarian cancer | 19193619 | CNVD |
Non-small cell lung cancer | 18676828 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Chordoma | 18071362 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Schizophrenia | 18923514 | CNVD |
Schizophrenia | 22241247 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Urothelial cell carcinoma | 18451213 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr2:209239000-209241600 | Enhancers | ES-UCSF4 Cell Line | embryonic stem cell |
2 | chr2:209239800-209241600 | Enhancers | HUES64 Cell Line | embryonic stem cell |
3 | chr2:209240000-209241600 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
4 | chr2:209241200-209243200 | Weak transcription | ES-I3 Cell Line | embryonic stem cell |
5 | chr2:209241600-209243000 | Weak transcription | H1 Cell Line | embryonic stem cell |
6 | chr2:209242800-209243400 | Weak transcription | Pancreas | Pancrea |
7 | chr2:209243200-209243800 | ZNF genes & repeats | ES-I3 Cell Line | embryonic stem cell |
8 | chr2:209243400-209243600 | Enhancers | Pancreas | Pancrea |
9 | chr2:209243600-209243800 | Enhancers | Liver | Liver |
10 | chr2:209243600-209245200 | Weak transcription | Pancreas | Pancrea |